Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Validation of a commercially available indirect assay for SARS-CoV-2 neutralising antibodies using a pseudotyped virus assay
Matthew J. Murray, Megan McIntosh, Claire Atkinson, et al.
Journal of Infection (2021) Vol. 82, Iss. 5, pp. 170-177
Open Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Performance evaluation of three automated quantitative immunoassays and their correlation with a surrogate virus neutralization test in coronavirus disease 19 patients and pre‐pandemic controls
Kiwook Jung, Sue Shin, Minjeong Nam, et al.
Journal of Clinical Laboratory Analysis (2021) Vol. 35, Iss. 9
Open Access | Times Cited: 65
Evaluation of the QuantiFERON SARS-CoV-2 interferon-ɣ release assay in mRNA-1273 vaccinated health care workers
Alexander Krüttgen, Hanna Klingel, Gerhard Haase, et al.
Journal of Virological Methods (2021) Vol. 298, pp. 114295-114295
Open Access | Times Cited: 42
Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies
Hadeel T. Zedan, Hadi M. Yassine, Duaa W. Al‐Sadeq, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 23
Two novel SARS-CoV-2 surrogate virus neutralization assays are suitable for assessing successful immunization with mRNA-1273
Alexander Krüttgen, Maike Lauen, Hanna Klingel, et al.
Journal of Virological Methods (2021) Vol. 299, pp. 114297-114297
Open Access | Times Cited: 30
The Comparability of Anti-Spike SARS-CoV-2 Antibody Tests is Time-Dependent: a Prospective Observational Study
Thomas Perkmann, Patrick Mucher, Nicole Perkmann‐Nagele, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 1
Open Access | Times Cited: 21
Dynamic of humoral response to SARS-CoV-2 anti-Nucleocapsid and Spike proteins after CoronaVac vaccination
Lucas Bochnia-Bueno, Sérgio Monteiro de Almeida, Sônia Mara Raboni, et al.
Diagnostic Microbiology and Infectious Disease (2021) Vol. 102, Iss. 3, pp. 115597-115597
Open Access | Times Cited: 23
Novel Competitive ELISA Utilizing Trimeric Spike Protein of SARS-CoV-2, Could Identify More Than RBD-RBM Specific Neutralizing Antibodies in Hybrid Sera
Petros Eliadis, Annie Mais, Alexandros Papazisis, et al.
Vaccines (2024) Vol. 12, Iss. 8, pp. 914-914
Open Access | Times Cited: 2
Immunogenicity of BNT162b2 COVID-19 vaccine in New Zealand adults
Frances Priddy, Michael A. Williams, Simon Carson, et al.
Vaccine (2022) Vol. 40, Iss. 34, pp. 5050-5059
Open Access | Times Cited: 12
Associations of HLA Polymorphisms with Anti-SARS-CoV-2 Spike and Neutralizing Antibody Titers in Japanese Rheumatoid Arthritis Patients Vaccinated with BNT162b2
Takashi Higuchi, Shomi Oka, Hiroshi Furukawa, et al.
Vaccines (2023) Vol. 11, Iss. 2, pp. 404-404
Open Access | Times Cited: 7
Semi-quantitative, high throughput analysis of SARS-CoV-2 neutralizing antibodies: Measuring the level and duration of immune response antibodies post infection/vaccination
Sean C. Taylor, Beth Hurst, Ian Martiszus, et al.
Vaccine (2021) Vol. 39, Iss. 39, pp. 5688-5698
Open Access | Times Cited: 14
Comparison of the Anti-SARS-CoV-2 Surrogate Neutralization Assays by TECOmedical and DiaPROPH-Med with Samples from Vaccinated and Infected Individuals
Lennart Münsterkötter, Moritz M. Hollstein, Andreas Hahn, et al.
Viruses (2022) Vol. 14, Iss. 2, pp. 315-315
Open Access | Times Cited: 9
An unexpected IgE anti-receptor binding domain response following natural infection and different types of SARS-CoV-2 vaccines
Amanda Izeli Portilho, Valéria Oliveira Silva, Hernan Hermes Monteiro da Costa, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Vaccine Ab neutralization against Omicron and SARS-CoV-2 variants using neutralization and specific ELISA assays
Valentine Marie Ferré, Samuel Lebourgeois, Houssem Redha Chenane, et al.
Journal of Infection (2022) Vol. 84, Iss. 6, pp. 834-872
Open Access | Times Cited: 8
Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
Rie Midorikawa, Moriyuki Nakama, Hiroshi Furukawa, et al.
Viruses (2022) Vol. 14, Iss. 5, pp. 965-965
Open Access | Times Cited: 8
Large inter-individual variability of cellular and humoral immunological responses to mRNA-1273 (Moderna) vaccination against SARS-CoV-2 in health care workers
Alexander Krüttgen, Gerhard Haase, Helga Haefner, et al.
Clinical and Experimental Vaccine Research (2022) Vol. 11, Iss. 1, pp. 96-96
Open Access | Times Cited: 7
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
S. Samoud, Jihène Bettaieb, Mariem Gdoura, et al.
Vaccines (2023) Vol. 11, Iss. 8, pp. 1329-1329
Open Access | Times Cited: 3
Anti-SARS-CoV-2 Spike Antibody Titers and Neutralizing Antibodies in Vaccinated Rheumatoid Arthritis Patients
Hiroshi Furukawa, Shomi Oka, Takashi Higuchi, et al.
Vaccines (2022) Vol. 10, Iss. 8, pp. 1365-1365
Open Access | Times Cited: 4
Utility of accessible SARS-CoV-2 specific immunoassays in vaccinated adults with a history of advanced HIV infection
Ludovica Ferrari, Alessandra Ruggiero, Chiara Stefani, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Development of pseudotyped VSV-SARS-CoV-2 spike variants for the assessment of neutralizing antibodies
Atike Nur Çimen, Gizem Çelebi Torabfam, Yeşim Tok, et al.
Bioanalysis (2024) Vol. 16, Iss. 21-22, pp. 1167-1177
Closed Access
A method comparison of three immunoassays for detection of neutralizing antibodies against SARS‐CoV‐2 receptor‐binding domain in individuals with adenovirus type‐5‐vectored COVID‐19 vaccination
Hui Chen, Wanwan Yu, Xiaojiao Gao, et al.
Journal of Clinical Laboratory Analysis (2022) Vol. 36, Iss. 4
Open Access | Times Cited: 3
Dynamic of humoral response to SARS-CoV-2 anti Nucleocapsid and Spike proteins after CoronaVac vaccination
Lucas Bochnia-Bueno, Sérgio Monteiro de Almeida, Sônia Mara Raboni, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 4
The comparability of Anti-Spike SARS-CoV-2 antibody tests is time-dependent: a prospective observational study
Thomas Perkmann, Patrick Mucher, Nicole Perkmann‐Nagele, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 3
Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies
Bo Kyeung Jung, Jung Hee Yoon, Joon‐Yong Bae, et al.
Diagnostics (2021) Vol. 11, Iss. 12, pp. 2193-2193
Open Access | Times Cited: 3
A practical approach to SARS-CoV-2 testing in a pre and post-vaccination era
Sean C. Taylor
Journal of Clinical Virology Plus (2021) Vol. 1, Iss. 4, pp. 100044-100044
Open Access | Times Cited: 2
SARS-CoV-2 neutralizing capacity among blood donors without prior COVID-19 symptomatic history vs. blood donors with prior COVID-19 symptomatic history: A comparative study
Ushasree Ravula, Srinivasa Rao Chunchu, Srujaleswari Mooli, et al.
Transfusion Clinique et Biologique (2022) Vol. 29, Iss. 2, pp. 107-111
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top